Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber ...

Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

To be accepted into a clinical trial, all potential participants must meet the "eligibility criteria" by having similar specific characteristics such as age, gender, disease stage, and previous ...

Dr. Elie Isenberg-Grzeda is an assistant professor in psychiatry at the University of Toronto. One of his primary research ...